Omaglip 12.5 mg Tablet
Omaglip 12.5 mg Tablet Uses, Dosage, Side Effects, Food Interaction and all others data.
Omaglip 12.5 mg Tablet has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
| Trade Name | Omaglip 12.5 mg Tablet |
| Generic | Omarigliptin |
| Omarigliptin Other Names | Omarigliptin |
| Weight | 12.5 mg |
| Type | Tablet |
| Formula | C17H20F2N4O3S |
| Weight | Average: 398.43 Monoisotopic: 398.12241802 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Navana Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | September 24, 2024 at 5:38 am |
Innovators Monograph
You find simplified version here Omaglip 12.5 mg Tablet
